Drugs@FDA document
LIPOSYN III 20% Letter · NDA 018970 SUPPL-13
Drugs@FDA document · HOSPIRA · Apr 18, 2003
Key facts
| Drug name | LIPOSYN III 20% |
|---|---|
| Document type | Letter |
| Application | NDA018970 |
| Submission | SUPPL-13 |
| Company | HOSPIRA |
| Document date | Apr 18, 2003 |
| FDA document | accessdata.fda.gov |
At a glance
- Manufacturing (CMC)-Control Document categories
- 1–9 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: